/
Analyses & Displays for Hepatotoxicity

Analyses & Displays for Hepatotoxicity

Aug 13, 2025

Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project LeadsEmail

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global

CURRENT STATUS (Updated Quarterly) 

  • Complete validation and publication of Stage 1 R programs.​
  • Complete full draft white paper for Stage 2.

Objectives & Deliverables

Timelines 
White PaperQ4 2023

Finalise Stage 2 of draft White Paper